MediPrint™ Ophthalmics successfully harnesses the power of digital printing, with its patented MediPrint™ process, to use contact lenses as a continuous drug delivery systems. Applying our cutting-edge patented technology and leveraging digital printing methods, we create enhanced contact lenses that help treat eye disease. Contact us today to learn more about using our broad and versatile technology platform for your next generation products.
Harnessing the power of the MediPrint™ process to print drug layers on FDA-approved contact lenses, MediPrint™ Ophthalmics uses its proprietary technology to develop contact lenses that provide sustained drug delivery of medications for ocular disease. This novel approach to treating glaucoma, dry eye, allergies, and other eye diseases is cost-effective and integrates seamlessly with existing manufacturing processes.
“We want to leave a footprint, creating a world in which all preventable blindness is eliminated.” ~ Praful Doshi, Founder